The blood–brain barrier is a specialized interface that regulates movement between the bloodstream and brain tissue. It is not a separate wall around the brain. Its key physical features are associated with the small blood vessels supplying the brain and the cells that support them.

A regulated interface, not a complete seal

Brain endothelial cells form tightly controlled connections and use transport systems to manage exchange. Nutrients must enter and waste must leave, while many potentially harmful substances are restricted. Supporting cells, including pericytes and astrocytes, contribute to the environment in which this barrier functions. NCBI Bookshelf: Blood–brain barrier physiology

Whether a molecule reaches brain tissue depends on more than its size. Chemical properties, transport mechanisms, breakdown and removal all matter. A substance may bind to a vessel surface without passing through to the brain.

Why the barrier matters in research

A compound can have a powerful effect on isolated neurons yet fail to reach them in a living organism. Brain-drug development must therefore address exposure as well as biological activity. Measuring a substance in a whole-brain sample may also require careful interpretation because blood remaining in vessels can contribute to the signal.

What “crosses the barrier” should mean

A strong claim should identify the exact molecule, whether it remained intact, the model studied and the amount reaching the relevant compartment. A cell-culture result does not automatically establish the same transport in a person. Barrier properties can also differ with age, disease and experimental conditions.

The barrier is a protective and actively regulated system, not an obstacle that is always desirable to weaken. Claims that a product “opens the blood–brain barrier” should not be treated as evidence of a health benefit.